Loading…
Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine
Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or del...
Saved in:
Published in: | The Journal of infectious diseases 1994-07, Vol.170 (1), p.51-59 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213 |
---|---|
cites | |
container_end_page | 59 |
container_issue | 1 |
container_start_page | 51 |
container_title | The Journal of infectious diseases |
container_volume | 170 |
creator | Hirsch, Vanessa M. Goldstein, Simoy Hynes, Noreen A. Elkins, William R. London, William T. Zack, Philip M. Montefiori, David Johnson, Philip R. |
description | Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P < .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection. |
doi_str_mv | 10.1093/infdis/170.1.51 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76575467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30133474</jstor_id><sourcerecordid>30133474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213</originalsourceid><addsrcrecordid>eNqFkUFv0zAYhi0EGmVw5oTkA-KW9fvixE6OqGNdpSKGug20i-U5NngkzrCTiv17HFq6406W_bzfI9svIW8RThBqNnfeNi7OUaT9SYnPyAxLJjLOkT0nM4A8z7Cq65fkVYx3AFAwLo7IUQVYlDnMSLwIfdv7H6ahi9Z5p1VL12owXj9Q5Ru6GcPWbdNhb-lnpdXv0US6dFvjqaLffvatoSuv9JAyQ3JsXOeUp6uuG33fGOu0-6e6dmGM9Fpp7bx5TV5Y1UbzZr8ek6uzT5eL82z9ZblafFxnusB8yBpQCAIK0BatKXTNAG7zyjKhS9CsAgtojBFNDVYALxUDjlbwXNdK8RzZMfmw896Hfrr3IDsXtWlb5U0_Ril4KcqCiyeDyDkHqCbjfBfUoY8xGCvvg-tUeJAIcupD7vqQqQ-Jspwm3u3V421nmkN-X0Di7_dcxfT3Niiv0_z_WIFVChWPmrs49OGAGSBjhZh4tuMuDubPgavwS6b3iVKef7-R9c3y68Xp2UbW7C9ke600</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16660081</pqid></control><display><type>article</type><title>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Hirsch, Vanessa M. ; Goldstein, Simoy ; Hynes, Noreen A. ; Elkins, William R. ; London, William T. ; Zack, Philip M. ; Montefiori, David ; Johnson, Philip R.</creator><creatorcontrib>Hirsch, Vanessa M. ; Goldstein, Simoy ; Hynes, Noreen A. ; Elkins, William R. ; London, William T. ; Zack, Philip M. ; Montefiori, David ; Johnson, Philip R.</creatorcontrib><description>Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P < .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/170.1.51</identifier><identifier>PMID: 8014520</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>AIDS ; AIDS Vaccines ; AIDS/HIV ; Amino Acid Sequence ; Animals ; Antibodies ; Antibodies, Viral - blood ; Antigens ; Antigens, Viral - blood ; Base Sequence ; Biological and medical sciences ; Blood plasma ; Cells, Cultured ; DNA, Viral ; human immunodeficiency virus ; Humans ; Immunization ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Infections ; Lymphocytes ; Macaca ; Macaca nemestrina ; Major Articles ; Medical sciences ; Molecular Sequence Data ; Monocytes - microbiology ; Sequence Homology, Amino Acid ; Simian Acquired Immunodeficiency Syndrome - immunology ; Simian Acquired Immunodeficiency Syndrome - mortality ; Simian Acquired Immunodeficiency Syndrome - physiopathology ; Simian Acquired Immunodeficiency Syndrome - prevention & control ; Simian immunodeficiency virus ; Simian Immunodeficiency Virus - immunology ; Simian Immunodeficiency Virus - physiology ; T-Lymphocyte Subsets - immunology ; Vaccination ; Vaccines, Inactivated - immunology ; Viral Vaccines - immunology ; Virus Latency ; Viruses</subject><ispartof>The Journal of infectious diseases, 1994-07, Vol.170 (1), p.51-59</ispartof><rights>Copyright 1994 The University of Chicago</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30133474$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30133474$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4182034$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8014520$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirsch, Vanessa M.</creatorcontrib><creatorcontrib>Goldstein, Simoy</creatorcontrib><creatorcontrib>Hynes, Noreen A.</creatorcontrib><creatorcontrib>Elkins, William R.</creatorcontrib><creatorcontrib>London, William T.</creatorcontrib><creatorcontrib>Zack, Philip M.</creatorcontrib><creatorcontrib>Montefiori, David</creatorcontrib><creatorcontrib>Johnson, Philip R.</creatorcontrib><title>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P < .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.</description><subject>AIDS</subject><subject>AIDS Vaccines</subject><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens</subject><subject>Antigens, Viral - blood</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Blood plasma</subject><subject>Cells, Cultured</subject><subject>DNA, Viral</subject><subject>human immunodeficiency virus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Infections</subject><subject>Lymphocytes</subject><subject>Macaca</subject><subject>Macaca nemestrina</subject><subject>Major Articles</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Monocytes - microbiology</subject><subject>Sequence Homology, Amino Acid</subject><subject>Simian Acquired Immunodeficiency Syndrome - immunology</subject><subject>Simian Acquired Immunodeficiency Syndrome - mortality</subject><subject>Simian Acquired Immunodeficiency Syndrome - physiopathology</subject><subject>Simian Acquired Immunodeficiency Syndrome - prevention & control</subject><subject>Simian immunodeficiency virus</subject><subject>Simian Immunodeficiency Virus - immunology</subject><subject>Simian Immunodeficiency Virus - physiology</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>Vaccination</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Viral Vaccines - immunology</subject><subject>Virus Latency</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqFkUFv0zAYhi0EGmVw5oTkA-KW9fvixE6OqGNdpSKGug20i-U5NngkzrCTiv17HFq6406W_bzfI9svIW8RThBqNnfeNi7OUaT9SYnPyAxLJjLOkT0nM4A8z7Cq65fkVYx3AFAwLo7IUQVYlDnMSLwIfdv7H6ahi9Z5p1VL12owXj9Q5Ru6GcPWbdNhb-lnpdXv0US6dFvjqaLffvatoSuv9JAyQ3JsXOeUp6uuG33fGOu0-6e6dmGM9Fpp7bx5TV5Y1UbzZr8ek6uzT5eL82z9ZblafFxnusB8yBpQCAIK0BatKXTNAG7zyjKhS9CsAgtojBFNDVYALxUDjlbwXNdK8RzZMfmw896Hfrr3IDsXtWlb5U0_Ril4KcqCiyeDyDkHqCbjfBfUoY8xGCvvg-tUeJAIcupD7vqQqQ-Jspwm3u3V421nmkN-X0Di7_dcxfT3Niiv0_z_WIFVChWPmrs49OGAGSBjhZh4tuMuDubPgavwS6b3iVKef7-R9c3y68Xp2UbW7C9ke600</recordid><startdate>19940701</startdate><enddate>19940701</enddate><creator>Hirsch, Vanessa M.</creator><creator>Goldstein, Simoy</creator><creator>Hynes, Noreen A.</creator><creator>Elkins, William R.</creator><creator>London, William T.</creator><creator>Zack, Philip M.</creator><creator>Montefiori, David</creator><creator>Johnson, Philip R.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19940701</creationdate><title>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</title><author>Hirsch, Vanessa M. ; Goldstein, Simoy ; Hynes, Noreen A. ; Elkins, William R. ; London, William T. ; Zack, Philip M. ; Montefiori, David ; Johnson, Philip R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>AIDS</topic><topic>AIDS Vaccines</topic><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens</topic><topic>Antigens, Viral - blood</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Blood plasma</topic><topic>Cells, Cultured</topic><topic>DNA, Viral</topic><topic>human immunodeficiency virus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Infections</topic><topic>Lymphocytes</topic><topic>Macaca</topic><topic>Macaca nemestrina</topic><topic>Major Articles</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Monocytes - microbiology</topic><topic>Sequence Homology, Amino Acid</topic><topic>Simian Acquired Immunodeficiency Syndrome - immunology</topic><topic>Simian Acquired Immunodeficiency Syndrome - mortality</topic><topic>Simian Acquired Immunodeficiency Syndrome - physiopathology</topic><topic>Simian Acquired Immunodeficiency Syndrome - prevention & control</topic><topic>Simian immunodeficiency virus</topic><topic>Simian Immunodeficiency Virus - immunology</topic><topic>Simian Immunodeficiency Virus - physiology</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>Vaccination</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Viral Vaccines - immunology</topic><topic>Virus Latency</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirsch, Vanessa M.</creatorcontrib><creatorcontrib>Goldstein, Simoy</creatorcontrib><creatorcontrib>Hynes, Noreen A.</creatorcontrib><creatorcontrib>Elkins, William R.</creatorcontrib><creatorcontrib>London, William T.</creatorcontrib><creatorcontrib>Zack, Philip M.</creatorcontrib><creatorcontrib>Montefiori, David</creatorcontrib><creatorcontrib>Johnson, Philip R.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirsch, Vanessa M.</au><au>Goldstein, Simoy</au><au>Hynes, Noreen A.</au><au>Elkins, William R.</au><au>London, William T.</au><au>Zack, Philip M.</au><au>Montefiori, David</au><au>Johnson, Philip R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1994-07-01</date><risdate>1994</risdate><volume>170</volume><issue>1</issue><spage>51</spage><epage>59</epage><pages>51-59</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Simian immunodeficiency virus (SIV) infection of macaques is a useful and relevant model for evaluating candidate human immunodeficiency virus (HIV) vaccines. One important feature of this model is that SIV vaccines can be evaluated for their ability to prevent infection as well as to prevent or delay the onset of AIDS. In the present study, a group of macaques was vaccinated with whole inactivated SIV and challenged with peripheral blood mononuclear cells from an SIV-infected macaque. This challenge represented a rigorous and realistic test of the immunization protocol. All macaques became infected after challenge; however, immunized animals survived significantly longer (P < .03) than naive controls. These data suggest that similar vaccines administered to humans at risk for HIV-1 infection might delay or prevent AIDS even if the vaccine failed to prevent infection.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>8014520</pmid><doi>10.1093/infdis/170.1.51</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 1994-07, Vol.170 (1), p.51-59 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_76575467 |
source | JSTOR Archival Journals and Primary Sources Collection; Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025 |
subjects | AIDS AIDS Vaccines AIDS/HIV Amino Acid Sequence Animals Antibodies Antibodies, Viral - blood Antigens Antigens, Viral - blood Base Sequence Biological and medical sciences Blood plasma Cells, Cultured DNA, Viral human immunodeficiency virus Humans Immunization Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infections Lymphocytes Macaca Macaca nemestrina Major Articles Medical sciences Molecular Sequence Data Monocytes - microbiology Sequence Homology, Amino Acid Simian Acquired Immunodeficiency Syndrome - immunology Simian Acquired Immunodeficiency Syndrome - mortality Simian Acquired Immunodeficiency Syndrome - physiopathology Simian Acquired Immunodeficiency Syndrome - prevention & control Simian immunodeficiency virus Simian Immunodeficiency Virus - immunology Simian Immunodeficiency Virus - physiology T-Lymphocyte Subsets - immunology Vaccination Vaccines, Inactivated - immunology Viral Vaccines - immunology Virus Latency Viruses |
title | Prolonged Clinical Latency and Survival of Macaques Given a Whole Inactivated Simian Immunodeficiency Virus Vaccine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A53%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolonged%20Clinical%20Latency%20and%20Survival%20of%20Macaques%20Given%20a%20Whole%20Inactivated%20Simian%20Immunodeficiency%20Virus%20Vaccine&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Hirsch,%20Vanessa%20M.&rft.date=1994-07-01&rft.volume=170&rft.issue=1&rft.spage=51&rft.epage=59&rft.pages=51-59&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/170.1.51&rft_dat=%3Cjstor_proqu%3E30133474%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-d0a107040cf1fe4c9300b28f37c50c380f01eee7d90f7065a3061f762c9aa6213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16660081&rft_id=info:pmid/8014520&rft_jstor_id=30133474&rfr_iscdi=true |